(Q33525308)

27 July 2017

title

Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk (English)

1 reference

27 July 2017

8

1 reference

27 July 2017

9

1 reference

27 July 2017

Carla Verri

6

0 references

Italia Bongarzone

object named as

Italia Bongarzone

11

0 references

Gabriella Sozzi

object named as

Gabriella Sozzi

7

0 references

Ugo Pastorino

object named as

Ugo Pastorino

10

0 references

author name string

Mattia Cremona

1

1 reference

27 July 2017

Elisa Calabrò

2

1 reference

27 July 2017

Giorgia Randi

3

1 reference

27 July 2017

Maida De Bortoli

4

1 reference

27 July 2017

Piera Mondellini

5

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 March 2010

1 reference

27 July 2017

1 reference

27 July 2017

volume

116

1 reference

27 July 2017

issue

5

1 reference

27 July 2017

page(s)

1326-1335

1 reference

Comparative study of serum amyloid A protein and C-reactive protein in disease

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

Computed tomography screening and lung cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Diagnostic accuracy of MALDI mass spectrometric analysis of unfractionated serum in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum amyloid A: an acute-phase protein involved in tumour pathogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum biomarkers for detection of breast cancers: A prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum protein profile analysis in patients with head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Proteomic classification of pancreatic adenocarcinoma tissue using protein chip technology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum proteomic features for detection of endometrial cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Application of serum SELDI proteomic patterns in diagnosis of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Application of serum protein fingerprint in diagnosis of papillary thyroid carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Uses and abuses of tumor markers in the diagnosis, monitoring, and treatment of primary and metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Evolution of the serum amyloid A (SAA) protein superfamily

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum amyloid A (SAA): a concise review of biology, assay methods and clinical usefulness

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Extracellular matrix-anchored serum amyloid A preferentially induces mast cell adhesion

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Serum amyloid a is a biomarker of acute exacerbations of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.24868

7 January 2021

Identifiers

DOI

10.1002/CNCR.24868

1 reference

27 July 2017

1 reference